SPDR S&P Biotech (ETF) (NYSEMKT:XBI)

CAPS Rating: 4 out of 5

Exchange traded funds

Recs

0
Player Avatar LifeScientist (30.70) Submitted: 11/28/2012 4:51:45 PM : Underperform Start Price: $88.42 XBI Score: +0.12

I agree that there is a long term trend but there is also a short term one as well. I red thumb the XBI and all biotech stock longs ( with exceptions ) until the XBI moves through the 50 day avg as a confirmation of an uptrend. With fiscal cliff and Europe worries, watch out for any ETF averages such as the XBI that closely follow the S& P and general market trends. I am new here so my CAPS score reflects my newness, but here to network and help out other traders evaluate the Trend Trade!

Featured Broker Partners


Advertisement